Integra LifeSciences Holdings ROE 2010-2024 | IART
Current and historical return on equity (ROE) values for Integra LifeSciences Holdings (IART) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Integra LifeSciences Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.01B | $1.55B | -0.45% |
| 2024-09-30 | $-0.01B | $1.52B | -0.38% |
| 2024-06-30 | $0.02B | $1.53B | 1.52% |
| 2024-03-31 | $0.04B | $1.60B | 2.48% |
| 2023-12-31 | $0.07B | $1.59B | 4.11% |
| 2023-09-30 | $0.10B | $1.58B | 5.93% |
| 2023-06-30 | $0.13B | $1.68B | 7.61% |
| 2023-03-31 | $0.17B | $1.68B | 10.02% |
| 2022-12-31 | $0.18B | $1.80B | 10.64% |
| 2022-09-30 | $0.17B | $1.72B | 10.35% |
| 2022-06-30 | $0.17B | $1.66B | 10.07% |
| 2022-03-31 | $0.16B | $1.62B | 9.59% |
| 2021-12-31 | $0.17B | $1.69B | 10.47% |
| 2021-09-30 | $0.22B | $1.63B | 13.82% |
| 2021-06-30 | $0.21B | $1.58B | 13.63% |
| 2021-03-31 | $0.17B | $1.53B | 11.74% |
| 2020-12-31 | $0.13B | $1.52B | 9.56% |
| 2020-09-30 | $0.06B | $1.40B | 4.07% |
| 2020-06-30 | $0.00B | $1.35B | -0.29% |
| 2020-03-31 | $0.03B | $1.34B | 1.87% |
| 2019-12-31 | $0.05B | $1.42B | 3.56% |
| 2019-09-30 | $0.06B | $1.39B | 4.30% |
| 2019-06-30 | $0.10B | $1.42B | 7.27% |
| 2019-03-31 | $0.08B | $1.40B | 5.99% |
| 2018-12-31 | $0.06B | $1.38B | 4.72% |
| 2018-09-30 | $0.08B | $1.37B | 6.77% |
| 2018-06-30 | $0.07B | $1.34B | 6.55% |
| 2018-03-31 | $0.07B | $1.00B | 7.32% |
| 2017-12-31 | $0.06B | $0.96B | 7.07% |
| 2017-09-30 | $0.05B | $0.91B | 5.49% |
| 2017-06-30 | $0.07B | $0.90B | 7.62% |
| 2017-03-31 | $0.07B | $0.85B | 8.10% |
| 2016-12-31 | $0.07B | $0.84B | 9.15% |
| 2016-09-30 | $0.06B | $0.82B | 7.76% |
| 2016-06-30 | $0.01B | $0.80B | 1.18% |
| 2016-03-31 | $0.00B | $0.78B | 0.13% |
| 2015-12-31 | $0.00B | $0.75B | -0.56% |
| 2015-09-30 | $0.00B | $0.73B | -0.28% |
| 2015-06-30 | $0.04B | $0.71B | 5.73% |
| 2015-03-31 | $0.04B | $0.69B | 5.78% |
| 2014-12-31 | $0.03B | $0.70B | 4.93% |
| 2014-09-30 | $0.03B | $0.69B | 4.56% |
| 2014-06-30 | $-0.01B | $0.69B | -1.42% |
| 2014-03-31 | $-0.01B | $0.68B | -2.03% |
| 2013-12-31 | $-0.02B | $0.67B | -3.65% |
| 2013-09-30 | $-0.02B | $0.50B | -4.11% |
| 2013-06-30 | $0.02B | $0.52B | 4.25% |
| 2013-03-31 | $0.03B | $0.51B | 5.63% |
| 2012-12-31 | $0.04B | $0.52B | 8.16% |
| 2012-09-30 | $0.03B | $0.53B | 6.68% |
| 2012-06-30 | $0.03B | $0.51B | 6.37% |
| 2012-03-31 | $0.02B | $0.51B | 4.75% |
| 2011-12-31 | $0.03B | $0.49B | 5.48% |
| 2011-09-30 | $0.04B | $0.50B | 8.20% |
| 2011-06-30 | $0.05B | $0.52B | 9.32% |
| 2011-03-31 | $0.06B | $0.53B | 12.46% |
| 2010-12-31 | $0.07B | $0.50B | 13.76% |
| 2010-09-30 | $0.06B | $0.47B | 13.52% |
| 2010-06-30 | $0.06B | $0.46B | 13.39% |
| 2010-03-31 | $0.06B | $0.46B | 12.90% |
| 2009-12-31 | $0.05B | $0.45B | 12.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.002B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.886B | 84.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.067B | 18.76 |
| Alcon (ALC) | Switzerland | $47.292B | 31.44 |
| Edwards Lifesciences (EW) | United States | $43.778B | 28.70 |
| IDEXX Laboratories (IDXX) | United States | $39.405B | 45.28 |
| DexCom (DXCM) | United States | $33.462B | 51.72 |
| IQVIA Holdings (IQV) | United States | $26.519B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.895B | 27.23 |
| STERIS (STE) | Ireland | $22.191B | 25.38 |
| Waters (WAT) | United States | $20.881B | 29.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.183B | 0.00 |
| Hologic (HOLX) | United States | $12.519B | 13.60 |
| Sysmex ADR (SSMXY) | Japan | $11.422B | 0.00 |
| Penumbra (PEN) | United States | $11.181B | 87.76 |
| Globus Medical (GMED) | United States | $9.966B | 23.37 |
| Masimo (MASI) | United States | $8.327B | 30.72 |
| Teleflex (TFX) | United States | $5.576B | 9.20 |
| Glaukos (GKOS) | United States | $5.174B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.170B | 21.85 |
| TransMedics (TMDX) | United States | $3.152B | 68.53 |
| PROCEPT BioRobotics (PRCT) | United States | $3.033B | 0.00 |
| Veracyte (VCYT) | United States | $2.444B | 34.30 |
| LivaNova (LIVN) | United Kingdom | $2.403B | 14.31 |
| Nihon Kohden (NHNKY) | Japan | $1.935B | 10.58 |
| Elekta AB (EKTAY) | Sweden | $1.893B | 17.01 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.515B | 0.00 |
| Artivion (AORT) | United States | $1.218B | 114.12 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.682B | 14.91 |
| IRadimed (IRMD) | United States | $0.670B | 33.98 |
| Beta Bionics (BBNX) | United States | $0.646B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| AxoGen (AXGN) | United States | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.480B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.411B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.399B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.338B | 7.18 |
| Neuronetics (STIM) | United States | $0.306B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.70 |
| 908 Devices (MASS) | United States | $0.207B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.157B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.18 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.42 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.04 |